753 related articles for article (PubMed ID: 26075331)
1. Ketamine and phencyclidine: the good, the bad and the unexpected.
Lodge D; Mercier MS
Br J Pharmacol; 2015 Sep; 172(17):4254-76. PubMed ID: 26075331
[TBL] [Abstract][Full Text] [Related]
2. N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants.
Krystal JH
Arch Gen Psychiatry; 2010 Nov; 67(11):1110-1. PubMed ID: 21041611
[No Abstract] [Full Text] [Related]
3. Ketamine analgesia, NMDA receptors and the gates of perception.
Oye I
Acta Anaesthesiol Scand; 1998 Aug; 42(7):747-9. PubMed ID: 9698947
[No Abstract] [Full Text] [Related]
4. [Receptor antagonist of NMDA and animal models of schizophrenia].
Bian SZ; Zhang J; Liu WL; Sun ZH; Gu ZL; Jiang XG
Fa Yi Xue Za Zhi; 2009 Dec; 25(6):443-6. PubMed ID: 20225623
[TBL] [Abstract][Full Text] [Related]
5. Ketamine for Treatment-Resistant Depression: a New Advocate.
Pérez-Esparza R
Rev Invest Clin; 2018; 70(2):65-7. PubMed ID: 29718013
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of ketamine and its metabolites as antidepressants.
Hess EM; Riggs LM; Michaelides M; Gould TD
Biochem Pharmacol; 2022 Mar; 197():114892. PubMed ID: 34968492
[TBL] [Abstract][Full Text] [Related]
7. Role of the nitric oxide donor sodium nitroprusside in the antidepressant effect of ketamine in mice.
Vogt MA; Vogel AS; Pfeiffer N; Gass P; Inta D
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1848-52. PubMed ID: 26138155
[TBL] [Abstract][Full Text] [Related]
8. Brain NMDA Receptors in Schizophrenia and Depression.
Adell A
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32585886
[TBL] [Abstract][Full Text] [Related]
9. Blocking NMDA receptor at rest: a possible alleviation of depression.
Lu W
Acta Pharmacol Sin; 2011 Sep; 32(9):1087-8. PubMed ID: 21804573
[No Abstract] [Full Text] [Related]
10. Ketamine and the potential role for rapid-acting antidepressant medications.
Krystal JH
Swiss Med Wkly; 2007 Apr; 137(15-16):215-6. PubMed ID: 17525875
[No Abstract] [Full Text] [Related]
11. Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat.
Amat-Foraster M; Celada P; Richter U; Jensen AA; Plath N; Artigas F; Herrik KF
Neuropharmacology; 2019 Nov; 158():107745. PubMed ID: 31445017
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive
Witkin JM; Mitchell SN; Wafford KA; Carter G; Gilmour G; Li J; Eastwood BJ; Overshiner C; Li X; Rorick-Kehn L; Rasmussen K; Anderson WH; Nikolayev A; Tolstikov VV; Kuo MS; Catlow JT; Li R; Smith SC; Mitch CH; Ornstein PL; Swanson S; Monn JA
J Pharmacol Exp Ther; 2017 Apr; 361(1):68-86. PubMed ID: 28138040
[TBL] [Abstract][Full Text] [Related]
13. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.
Bubeníková-Valesová V; Horácek J; Vrajová M; Höschl C
Neurosci Biobehav Rev; 2008 Jul; 32(5):1014-23. PubMed ID: 18471877
[TBL] [Abstract][Full Text] [Related]
14. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.
Krystal JH; D'Souza DC; Mathalon D; Perry E; Belger A; Hoffman R
Psychopharmacology (Berl); 2003 Sep; 169(3-4):215-33. PubMed ID: 12955285
[TBL] [Abstract][Full Text] [Related]
15. NMDA receptors as therapeutic targets for depression treatment: Evidence from clinical to basic research.
Lv S; Yao K; Zhang Y; Zhu S
Neuropharmacology; 2023 Mar; 225():109378. PubMed ID: 36539011
[TBL] [Abstract][Full Text] [Related]
16. Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.
Newport DJ; Carpenter LL; McDonald WM; Potash JB; Tohen M; Nemeroff CB;
Am J Psychiatry; 2015 Oct; 172(10):950-66. PubMed ID: 26423481
[TBL] [Abstract][Full Text] [Related]
17. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia.
Jentsch JD; Roth RH
Neuropsychopharmacology; 1999 Mar; 20(3):201-25. PubMed ID: 10063482
[TBL] [Abstract][Full Text] [Related]
18. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
Miller OH; Moran JT; Hall BJ
Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
[TBL] [Abstract][Full Text] [Related]
19. How does ketamine elicit a rapid antidepressant response?
Kavalali ET; Monteggia LM
Curr Opin Pharmacol; 2015 Feb; 20():35-9. PubMed ID: 25462290
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antidepressant-like and abuse-related effects of phencyclidine in rats.
Hillhouse TM; Porter JH; Negus SS
Drug Dev Res; 2014 Dec; 75(8):479-88. PubMed ID: 25315690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
